前庭性偏头痛治疗的系统综述与荟萃分析
该研究通过系统检索 PubMed、Scopus、PsycINFO 和 Cochrane Library 截至 2019 年 4 月的文献,纳入 13 项关于前庭性偏头痛预防性治疗的研究进行荟萃分析。结果显示所有分析的治疗方案在眩晕残障量表、眩晕频率和主观改善百分比上均显示改善,但因异质性显著且缺乏标准化报告,无法确定首选治疗模式。
要点
- 抗癫痫药、钙通道阻滞剂、三环类抗抑郁药、β受体阻滞剂、SNRI 及前庭康复均显示改善结局。
- 因异质性和报告不统一,无法确定前庭性偏头痛的首选预防治疗方案。
- 治疗选择可能受医生熟悉度、患者共病及副作用谱影响。
核心结论
- 多种治疗模式被评估用于前庭性偏头痛的预防性治疗,但无法确定首选方案。
研究设计与样本
- 系统综述与荟萃分析,检索 PubMed、Scopus、PsycINFO 和 Cochrane Library 截至 2019 年 4 月的随机对照或观察性研究,最终纳入 13 项研究。
主要发现
- 纳入患者平均年龄 43.3 岁,女性与男性比例为 2.1:1。
- 所有分析的治疗方案在眩晕残障量表、眩晕频率和主观改善百分比上均显示改善。
- 因显著异质性和缺乏标准化结局报告,无法确定首选治疗模式。
关键数值与推荐
- 治疗药物类别包括抗癫痫药、钙通道阻滞剂、三环类抗抑郁药、β受体阻滞剂、5-羟色胺和去甲肾上腺素再摄取抑制剂及前庭康复。
临床怎么用
- 临床选择预防性治疗时需考虑医生熟悉度、患者共病及不同干预的副作用谱。
局限性
- 纳入研究存在显著异质性且结局报告缺乏标准化。
- 未来需限制性纳入标准及可推广的标准化结局指标的随机对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the efficacy of the various therapies used for the prevention of vestibular migraine (VM). METHODS: Primary studies were identified though PubMed, Scopus, PsycINFO, and Cochrane Library by two independent investigators for articles published through April 2019. The search identified randomized comparison or observational studies pertaining to vestibular migraine treatment. Meta-analysis was performed on pre- and posttreatment Dizziness Handicap Inventory, vertigo frequency, and percentage of perceived improvement. RESULTS: Literature search identified 13 studies that reported sufficient outcome measures to be included in the analysis. Patients with VM had a mean age of 43.3 years with female-to-male gender ratio of 2.1:1. Classes of therapeutic agents included antiepileptic drugs, calcium channel blockers, tricyclic antidepressants, β-blockers, serotonin and norepinephrine reuptake inhibitors, and vestibular rehabilitation. All treatment options that were analyzed demonstrated improvement in all of the outcome parameters, but due to significant heterogeneity and lack of standardized reporting on outcomes, establishment of preferred treatment modality could not be determined. CONCLUSIONS: Various treatment modalities have been evaluated for preventative treatment of VM. Physician familiarity, patient comorbidities, and the side-effect profiles of various interventions likely influence the selection of intervention. Future randomized controlled trials with restrictive inclusion criteria and generalizable standardized outcome measures will allow for more robust meta-analyses and for more evidence-based treatment of vestibular migraines. Laryngoscope, 131:186-194, 2021.
引用
- Byun YJ, Levy DA, Nguyen SA, et al. Treatment of Vestibular Migraine: A Systematic Review and Meta-analysis. Laryngoscope. 2020. PMID: 32083732. doi:10.1002/lary.28546
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。